4//SEC Filing
IGEN INTERNATIONAL INC /DE 4
Accession 0001164710-04-000030
CIK 0000916304operating
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:54 AM ET
Size
8.7 KB
Accession
0001164710-04-000030
Insider Transaction Report
Form 4
SALAMANS ROBERT R
Director
Transactions
- Disposition to Issuer
Option to Buy
2004-02-13−10,000→ 0 totalExercise: $6.25From: 1995-08-25Exp: 2005-08-25→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This option, which provided for vesting in installments, was cancelled pursuant to the terms of the Agreement and Plan of Merger ("Agreement and Plan of Merger") dated July 24, 2003 among Roche Holding Ltd, 66 Acquisition Corporation II, IGEN International, Inc. and BioVeris Corporation (formerly known as IGEN Integrated Healthcare, LLC) and in accordance therewith, each share under this option was exchanged for a cash payment of $41.00 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation. The Agreement and Plan of Merger is more fully described in the Registration Statement on Form S-4 (333-109196) as filed with the Securities and Exchange Commission on January 13, 2004.
- [F2]This option, which provided for vesting in installments, was cancelled pursuant to the terms of the Agreement and Plan of Merger, and in accordance therewith, each share under option was exchanged for a cash payment of $23.95 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation.
Documents
Issuer
IGEN INTERNATIONAL INC /DE
CIK 0000916304
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000916304
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 8:54 AM ET
- Size
- 8.7 KB